Coronavirus cure can only be found out after we can understand how the virus exactly works and what can be done to stop the infection from spreading. A recent study indicates that the COVID-19 virus causes the infected cells to sprout tentacles which can attack the nearby cells and poke holes in them to transfer the disease inside them.
The horrible truth about coronavirus was discovered by the University of California, San Francisco. UCSF’s Director of the Quantitative Biosciences Institute, Professor Nevan Krogan said that there are long strings that are poking holes in the nearby cells to transfer the virus through tubes formed. It is the main reason why the infection is so speedy and that research will be now used to find a solid cure for coronavirus.
Tentacle Discovery will help in Finding a Coronavirus Cure
The report says that the tentacle discovery could prove to be very much useful in finding a coronavirus cure. We can found a number of drugs to treat the COVID-19 infection which were previously used to treat cancer and other diseases.
Most of the virus can’t infect the cells to grow tentacles, even if they do there are not so many branches as found in Sars-Cov-2, the scientific name of the COVID-19 virus. Professor Krogan also added that anticancer and antiviral drugs have an overlap, where diseases such as HIV, cancer and coronavirus are always looking out for the Achilles heel of the cell.
Coronavirus Vaccine and Source of Virus
There are currently five drugs used in the treatment of coronavirus that will soon undergo trials and have been approved by the NIH. It was earlier estimated that the coronavirus is not made in a bio lab in Wuhan, China, but the recent study indicates that the virus is artificial.
The human trails for the coronavirus vaccine will start from August and hopefully, by the end of the year, we have a permanent solution to cure the pandemic. Here are the leading names in coronavirus vaccine and cure research, the drugs which are most successful till now.
- Remdesivir by Gilead Science
- Silmitasertib, made by Taiwan-based Senhwa Biosciences
- Xospata (aka gilteritinib) made by Japan-based Astellas Pharma
- Eli Lily’s FDA-approved abemaciclib (Verzenio)
- Ralimetinib, and Dasatinib, made by Bristol-Meyers Squibb
No comments:
Post a Comment